Abstract:Abstract Ginseng and related herbs have been used for various health benefits in over 2000 years. However, their mechanisms of action are not fully understood. In our laboratory, we have been isolating and characterizing ginsenosides as anticancer agents. 20(S)-25-methoxyl-dammarane-3α, 12α, 20-triol (25-OCH3-PPD), a newly identified natural product from Panax notoginseng, has shown activities against a variety of cancer cells in vitro and in vivo. However, the mechanisms of action for the novel anticancer agent are largely unknown. In this study, we discovered a novel mode of action for 25-OCH3-PPD: direct inhibition of the MDM2 oncoprotein. It is well established that the MDM2 oncogene plays a major role in human cancer development and progression. Its tumorigenic properties are associated with both p53-dependent and -independent pathways. We first demonstrated that, in a dose-dependent manner, 25-OCH3-PPD inhibited MDM2 expression in human breast cancer cell lines with different p53 backgrounds, including MCF-7 (p53 wild type and p53 knockout) and MDA-MB-468 (p53 mutate) cells. We further found that 25-OCH3-PPD inhibited MDM2 expression at the transcriptional level, affecting MDM2 promoter activity. We also observed that 25-OCH3-PPD decreased the survival, inhibited proliferation, induced apoptosis and led to G1 cell cycle arrest in the test breast cancer cells. The anti-cancer activities of 25-OCH3-PPD were reduced in MCF7 inducible MDM2-overexpression cells, further supporting the relevance of the MDM2 inhibitory effect to its anti-cancer activity. Moreover, 25-OCH3-PPD inhibited the growth of breast cancer xenograft tumors in vivo which was associated with its MDM2 inhibitory effects. 25-OCH3-PPD demonstrated low toxicity to non-cancer cells, and did not have any observable toxicity in animals. In summary, our preclinical data indicate that 25-OCH3-PPD is a potential therapeutic agent and that further preclinical and clinical development of this agent is warranted. These results also provide an example of a natural product/oncogene interaction as a novel mechanism of action for chemotherapeutic agents. (This work was supported by NIH/NCI grants R01 CA112029 and R01 CA121211 and a grant (BCTR070731) from Susan G Komen for the Cure.) Citation Format: {Authors}. {Abstract title} [abstract]. In: Proceedings of the 103rd Annual Meeting of the American Association for Cancer Research; 2012 Mar 31-Apr 4; Chicago, IL. Philadelphia (PA): AACR; Cancer Res 2012;72(8 Suppl):Abstract nr 1996. doi:1538-7445.AM2012-1996

20(S)-Protopanaxadiol-induced Apoptosis in MCF-7 Breast Cancer Cell Line Through the Inhibition of PI3K/AKT/mTOR Signaling Pathway

20(S)-Protopanaxadiol Induces Human Breast Cancer MCF-7 Apoptosis Through a Caspase-Mediated Pathway

20(S)-protopanaxadiol triggers mitochondrial-mediated apoptosis in human lung adenocarcinoma A549 cells via inhibiting the PI3K/Akt signaling pathway.

20(S)-Protopanaxadiol induces apoptosis in human hepatoblastoma HepG2 cells by downregulating the protein kinase B signaling pathway.

Ginsenoside Ppd'S Antitumor Effect Via Down-Regulation Of Mtor Revealed By Super-Resolution Imaging

Targeting the ROS/PI3K/AKT/HIF‐1α/HK2 Axis of Breast Cancer Cells: Combined Administration of Polydatin and 2‐Deoxy‐d‐glucose

Ginsenoside 20(S)-protopanaxadiol inhibits triple-negative breast cancer metastasis in vivo by targeting EGFR-mediated MAPK pathway

Potential Mechanism of Mycelium Polysaccharide from Pholiota Dinghuensis Bi in Regulating the Proliferation and Apoptosis of Human Breast Cancer MCF-7 Cells Through P38/mapk Pathway

Synthesis, Biological Evaluation and Mechanism Study Based on Network Pharmacology of Amino Acids Esters of 20(S)-Protopanaxadiol As Novel Anticancer Agents

20(S)-Protopanaxadiol Blocks Cell Cycle Progression by Targeting Epidermal Growth Factor Receptor.

20(S)-Protopanaxadiol Inhibits Angiotensin II-Induced Epithelial- Mesenchymal Transition by Downregulating SIRT1.

Natural Product Ginsenoside 25-Och3-ppd Inhibits Breast Cancer Growth and Metastasis Through Down-Regulating Mdm2

Inductive effect of 20 (s)-proto-panaxdiol on apoptosis of human prostate cancer PC3 cells cultivated in vitro and its mechanism

Effect of 20(S)-Protopanaxadiol on SMMC-7721 Human Liver Cancer in Vivo and in Vitro

Ginsenoside (20S)-protopanaxatriol induces non-protective autophagy and apoptosis by inhibiting Akt/mTOR signaling pathway in triple-negative breast cancer cells

TRAIL Pathway is Associated with Inhibition of Colon Cancer by Protopanaxadiol.

Experimental Therapy of Prostate Cancer with Novel Natural Product Anti-Cancer Ginsenosides

Anticancer Efficacy And Mechanism Of Action Of Novel Ginsenoside 25-Och3-Ppd, A Natural Product Mdm2 Inhibitor

Polydatin Down-Regulates the Phosphorylation Level of Creb and Induces Apoptosis in Human Breast Cancer Cell

Anti-Proliferation of Triple-Negative Breast Cancer Cells with Physagulide P: Ros/Jnk Signaling Pathway Induces Apoptosis and Autophagic Cell Death

Anti-Tumor Activity of Three Novel Derivatives of Ginsenoside on Colorectal Cancer Cells